Nuuron Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
Nuuron General Information
Description
Developer of digital memory pacemaker intended to re-enable patients with Alzheimer's disease to store and recall memories again. The company's platform algorithms produce ultra-high frequency, digital photonic stimuli that activate the memory center by using the retina as a computer-brain interface, enabling patients to improve the storage and retrieval of information.
Contact Information
Website
www.nuuron.comCorporate Office
- Torstrasse 117
- 10119 Berlin
- Germany
Corporate Office
- Torstrasse 117
- 10119 Berlin
- Germany
Nuuron Timeline
Nuuron Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Apr-2026 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 31-Oct-2024 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nuuron Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nuuron Patents
Nuuron Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024235306-A1 | Device for inducing high-frequency oscillations in a brain | Pending | 13-Mar-2023 | ||
| EP-4680331-A1 | Device for inducing high-frequency oscillations in a brain | Pending | 13-Mar-2023 | ||
| WO-2024189112-A1 | Device for inducing high-frequency oscillations in a brain | Inactive | 13-Mar-2023 | A61N5/0622 |
Nuuron Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nuuron Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arcas Ventures | Venture Capital | Minority | ||
| Futury Capital | Growth/Expansion | Minority | ||
| BIF Partners | Venture Capital | Minority | ||
| Business Angels Club Berlin-Brandenburg | Angel Group | Minority | ||
| Caesar Ventures | Venture Capital | Minority |
Nuuron FAQs
-
When was Nuuron founded?
Nuuron was founded in 2023.
-
Where is Nuuron headquartered?
Nuuron is headquartered in Berlin, Germany.
-
What is the size of Nuuron?
Nuuron has 7 total employees.
-
What industry is Nuuron in?
Nuuron’s primary industry is Therapeutic Devices.
-
Is Nuuron a private or public company?
Nuuron is a Private company.
-
What is Nuuron’s current revenue?
The current revenue for Nuuron is .
-
How much funding has Nuuron raised over time?
Nuuron has raised $3.82M.
-
Who are Nuuron’s investors?
Arcas Ventures, Futury Capital, BIF Partners, Business Angels Club Berlin-Brandenburg, and Caesar Ventures are 5 of 8 investors who have invested in Nuuron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
